Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON — Original Application (Fresenius Kabi USA, LLC)
The FDA approved Fresenius Kabi USA, LLC's original application for Palonosetron, a 5-HT3 receptor antagonist used to prevent chemotherapy-i…
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved a generic palonosetron hydrochloride product from Mylan Institutional LLC through an original ANDA, intended to prevent postope…
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved Palonosetron hydrochloride as a generic product through an Original Application filed by Sagent Pharmaceuticals.
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for a generic palonosetron hydrochloride product to prevent chemotherapy- and surgery-induc…
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: US Phase III Study of APD421 in PONV [Phase 3]
The Phase 3 US study of APD421 for postoperative nausea and vomiting has completed. Trial results were posted on 2018-09-06.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting [Phase 2]
Phase 2 trial updating the effect of ginger on the incidence of postoperative nausea and vomiting.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients [Phase 4]
Phase 4 trial comparing two doses of palonosetron for prevention of postoperative nausea and vomiting in obese patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Sugammadex Versus Neostigmine for Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery [Phase 3]
A Phase 3 trial comparing sugammadex to neostigmine for prevention of postoperative nausea and vomiting after laparoscopic gynecologic surge…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery [NA]
A completed trial comparing palonosetron alone versus palonosetron with dexamethasone for preventing postoperative vomiting in patients rece…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting [NA]
A clinical trial sponsored by Assiut University evaluating intrathecal atropine to prevent postoperative nausea and vomiting has completed.
-
FDA approval · 2018-04-23FDA Approved: ONDANSETRON — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for ondansetron hydrochloride from Taro Pharmaceuticals U.S.A., Inc., for an already approved pr…
-
CLINICAL_TRIALS research · 2018-04-20Clinical Trial Update: Effect of Ramosetron on Post-discharge Nausea and Vomiting [NA]
Clinical trial investigating whether Ramosetron reduces post-discharge nausea and vomiting in patients undergoing hysteroscopy; the current …
-
CLINICAL_TRIALS research · 2018-03-30Clinical Trial Update: Comp Granisetron Midazolam Comb in Lap Children [Phase 3]
A Phase 3 clinical trial from Assiut University is evaluating a granisetron and midazolam combination for preventing postoperative nausea an…
-
FDA approval · 2018-03-23FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Teva Parenteral Medicines, Inc.)
FDA approved Teva Parenteral Medicines' palonosetron hydrochloride injection as an original application (ANDA 090713), establishing bioequiv…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA) [NA]
Completed clinical trial evaluating whether adding ondansetron to morphine in patient-controlled analgesia reduces postoperative nausea and …
-
FDA approval · 2018-03-14FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for ondansetron hydrochloride from Chartwell RX, LLC, under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Ramosetron Pre-treatment for PONV and QT Prolongation [Phase 4]
Phase 4 trial evaluating Ramosetron as pre-treatment for postoperative nausea and vomiting and QT prolongation, with the study status report…
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for ondansetron under an ANDA held by PAI Holdings dba PAI Pharma, indicating a supplemental reg…
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, granting approval of this generic p…
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for ondansetron hydrochloride (ONDANSETRON) from NorthStar Rx LLC, resulting in updated labeling for…
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc., marking an update to the generic's labeling or po…
-
FDA label_change · 2018-03-07FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
FDA listing shows a supplemental application for ondansetron by AvPAK, likely related to changes to labeling or approved indications for thi…
-
FDA approval · 2018-02-26FDA Approved: ONDANSETRON — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for ondansetron filed by Chartwell RX, LLC.
-
FDA approval · 2018-02-26FDA Approved: ONDANSETRON — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for ondansetron submitted by Chartwell RX, LLC, approving a generic ondansetron product.
-
FDA approval · 2018-02-13FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ondansetron submitted by Glenmark Pharmaceuticals Inc., USA.